Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Baxter
Julphar
Boehringer Ingelheim
McKinsey
Chinese Patent Office
Johnson and Johnson
Colorcon
Citi

Generated: June 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 009864

« Back to Dashboard

NDA 009864 describes CORTEF, which is a drug marketed by Pharmacia And Upjohn and is included in five NDAs. It is available from four suppliers. Additional details are available on the CORTEF profile page.

The generic ingredient in CORTEF is hydrocortisone acetate. There are sixty-four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the hydrocortisone acetate profile page.
Summary for 009864
Tradename:CORTEF
Applicant:Pharmacia And Upjohn
Ingredient:hydrocortisone
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 009864

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength50MG/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Boehringer Ingelheim
Healthtrust
Fish and Richardson
Queensland Health
Cipla
Chubb
Merck
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.